Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 10:31 PM ET

Date/Time Source News Release
05/29/2025 08:00 AM EDT GlobeNewswire Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
05/12/2025 04:05 PM EDT GlobeNewswire Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
03/31/2025 08:00 AM EDT GlobeNewswire Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
03/19/2025 07:00 AM EDT GlobeNewswire Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
03/06/2025 04:01 PM EST GlobeNewswire Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
02/19/2025 09:15 AM EST GlobeNewswire NAYA Biosciences Announces Nomination of New Board Members
11/05/2024 08:00 AM EST GlobeNewswire Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/01/2024 08:00 AM EDT GlobeNewswire Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
10/07/2024 04:01 PM EDT GlobeNewswire Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
09/23/2024 07:00 AM EDT GlobeNewswire Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
Page